Anne Lok

Nantes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Journal: Cancer
Published: November 15, 2025

BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study.

BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study.

Journal: British journal of haematology
Published: October 02, 2025

Preemptive Immunoglobulin Prophylaxis Reduces Infections in Patients Treated With Anti-BCMA Bispecific Antibodies.

Preemptive Immunoglobulin Prophylaxis Reduces Infections in Patients Treated With Anti-BCMA Bispecific Antibodies.

Journal: Clinical lymphoma, myeloma & leukemia
Published: September 12, 2025

Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Journal: Leukemia
Published: October 31, 2024

Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.

Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.

Journal: American journal of hematology
Published: August 22, 2023

B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy
Published: September 25, 2021

Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant.

Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant.

Journal: British journal of haematology
Published: September 02, 2021

Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.

Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.

Journal: British journal of haematology
Published: August 19, 2021

Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.

Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.

Journal: EJHaem
Published: May 04, 2021

Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.

Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.

Journal: Acta oncologica (Stockholm, Sweden)
Published: October 28, 2020

Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience.

Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma: a single-center experience.

Journal: Bone marrow transplantation
Published: June 11, 2020

A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.

A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.

Journal: Cancer medicine
Published: April 17, 2020
Showing 1-12 of 29

Last Updated: 09/26/2026